本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioNTech SE

95.84
-1.1200-1.16%
盘后:97.001.16+1.21%18:26 EDT
成交量:127.70万
成交额:1.23亿
市值:240.75亿
市盈率:-12.33
高:98.60
开:97.61
低:95.75
收:96.96
52周最高:124.00
52周最低:79.52
股本:2.51亿
流通股本:1.09亿
量比:1.12
换手率:1.17%
股息:- -
股息率:- -
每股收益(TTM):-7.7726
每股收益(LYR):-5.5184
净资产收益率:-9.30%
总资产收益率:-5.41%
市净率:1.22
市盈率(LYR):-17.37

数据加载中...

2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 | BioNTech 大股东 ATHOS KG 拟减持55605股,总价约693万美元
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 | BioNTech SE 10%股东 ATHOS KG 拟减持50万股,总价约6170万美元
2024/09/16

关联方拟减持公告

Form 144 | BioNTech SE 股东 ATHOS KG 拟减持90000股,总价约1134万美元
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities